PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
Oncogene, 2010 - nature.com
Although the transient receptor potential melastatin 8 (TRPM8) cold receptor is highly
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
D Gkika, M Flourakis, L Lemonnier… - …, 2010 - search.ebscohost.com
Although the transient receptor potential melastatin 8 (TRPM8) cold receptor is highly
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
[引用][C] PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
D GKIKA, M FLOURAKIS, L LEMONNIER… - Oncogene …, 2010 - pascal-francis.inist.fr
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma
membrane expression CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
membrane expression CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
D Gkika, M Flourakis, L Lemonnier, N Prevarskaya - Oncogene, 2010 - europepmc.org
Although the transient receptor potential melastatin 8 (TRPM8) cold receptor is highly
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
D Gkika, M Flourakis, L Lemonnier, N Prevarskaya - Oncogene, 2010 - hal.science
Although the transient receptor potential melastatin 8 (TRPM8) cold receptor is highly
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
[PDF][PDF] PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
D Gkika, M Flourakis, L Lemonnier, N Prevarskaya - Oncogene, 2010 - researchgate.net
In developed countries, prostate cancer (PCa) is the second most frequently diagnosed
cancer, and the third most common cause of death from cancer in men. In late PCa stages …
cancer, and the third most common cause of death from cancer in men. In late PCa stages …
[PDF][PDF] PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
D Gkika, M Flourakis, L Lemonnier, N Prevarskaya - Oncogene, 2010 - academia.edu
In developed countries, prostate cancer (PCa) is the second most frequently diagnosed
cancer, and the third most common cause of death from cancer in men. In late PCa stages …
cancer, and the third most common cause of death from cancer in men. In late PCa stages …
[引用][C] PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
D Gkika, M Flourakis, L Lemonnier, N Prevarskaya - Oncogene, 2010 - cir.nii.ac.jp
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane
expression | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
expression | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[引用][C] PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
D Gkika, M Flourakis, L Lemonnier, N Prevarskaya - Oncogene, 2010 - hal.univ-lille.fr
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane
expression - Université de Lille Accéder directement au contenu Documentation FR Se …
expression - Université de Lille Accéder directement au contenu Documentation FR Se …
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
D Gkika, M Flourakis, L Lemonnier… - …, 2010 - pubmed.ncbi.nlm.nih.gov
Although the transient receptor potential melastatin 8 (TRPM8) cold receptor is highly
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …